Wed, December 10, 2008
[ Wed, Dec 10th 2008 ] - Market Wire
Panacos Provides Update on Corporate Strategy
[ Wed, Dec 10th 2008 ] - Market Wire
Salix In-Licenses Crofelemer from Napo Pharmaceuticals
[ Wed, Dec 10th 2008 ] - Market Wire
R sultats prometteurs de deux essais soulignant l .. par voie orale Le compos Pomalidomide a t pr s
[ Wed, Dec 10th 2008 ] - James Betz
Biotivia is the first supplement company to utili .. technology to protect resveratrol from oxidation.
[ Wed, Dec 10th 2008 ] - Market Wire
Symbollon Pharmaceuticals, Inc.: Symbollon Enters .. ement Covering Upper Respiratory Tract Technology
[ Wed, Dec 10th 2008 ] - Market Wire
AspenBio Pharma, Inc.: AspenBio Completes Clinica .. r AppyScore, World's First Blood-Based Diagnostic
[ Wed, Dec 10th 2008 ] - Market Wire
Lakeland Industries, Inc.: Lakeland Industries, I .. ports Fiscal 2009 Third Quarter Financial Results
[ Wed, Dec 10th 2008 ] - Market Wire
Seattle Genetics Announces Interim Safety Analysi .. ntinuation of Lintuzumab Phase IIb Clinical Trial
[ Wed, Dec 10th 2008 ] - Market Wire
OR-Live, Inc.: REMINDER: OR-Live.com Presents: Ea .. ment of Mitral Valve Disease: Clinical Guidelines
[ Wed, Dec 10th 2008 ] - Market Wire
Viel versprechende Ergebnisse aus zwei Studien zu .. twicklung befindlichen, oralen IMiDS -Pr parats P
[ Wed, Dec 10th 2008 ] - Market Wire
Veelbelovende resultaten uit twee onderzoeken bet .. menstelling pomalidomide gepresenteerd tijdens de
[ Wed, Dec 10th 2008 ] - Market Wire
Risultati promettenti di due studi del composto I .. lidomide, sono presentati alla riunione dell'Amer
Tue, December 9, 2008
[ Tue, Dec 09th 2008 ] - Market Wire
Alphatec Spine Completes $30 Million Credit Facility
[ Tue, Dec 09th 2008 ] - Market Wire
CombinatoRx Presents New Data on B-Cell Malignancy Programs
[ Tue, Dec 09th 2008 ] - Market Wire
Des donn es actualis es portant sur le REVLIMID .. my lome multiple r cemment diagnostiqu font tat
[ Tue, Dec 09th 2008 ] - Market Wire
Curves International and Healthways SilverSneakers Fitness Program Announce Partnership
[ Tue, Dec 09th 2008 ] - Market Wire
Cavit Sciences, Inc.: Cavit Sciences Is Now in the Hands of the Shareholders and Moving Forward
[ Tue, Dec 09th 2008 ] - Market Wire
Stellar Pharmaceuticals Inc.: Stellar Pharmaceuti .. eement For Distribution and Sale of Uracyst(R) in
[ Tue, Dec 09th 2008 ] - Market Wire
Candela Files Requests for Re-Examination of Palomar Hair Patents
[ Tue, Dec 09th 2008 ] - Market Wire
Alnylam Provides Update on Kreutzer-Limmer Patent Family
[ Tue, Dec 09th 2008 ] - Market Wire
Presentazione all'ASH di uno studio di fase I su .. e SMD ad alto rischio riporta che la combinazione
[ Tue, Dec 09th 2008 ] - Market Wire
Dyloject " Significantly Reduces Moderate-to-Seve .. Pain in Pivotal Phase 3 Orthopedic Surgical Trial
[ Tue, Dec 09th 2008 ] - Market Wire
Geactualiseerde REVLIMID -gegevens bij pas gediag .. maken melding van nooit geziene overlevingspercen
[ Tue, Dec 09th 2008 ] - Market Wire
Molina Healthcare Renews and Replaces Its Universal Shelf Registration Statement
[ Tue, Dec 09th 2008 ] - Market Wire
AngioDynamics Appoints Vice President, Regulatory, Quality and Clinical Affairs
Mon, December 8, 2008
[ Mon, Dec 08th 2008 ] - Market Wire
Acusphere, Inc. Announces Posting of Briefing Doc .. nal Drugs Advisory Committee Meeting on Imagify "
[ Mon, Dec 08th 2008 ] - Market Wire
Bio-Imaging Technologies Partners with AG Mednet .. fer Complete Imaging Solution for Clinical Trials
[ Mon, Dec 08th 2008 ] - Market Wire
Neoprobe Achieves Final Milestone in $13 Million .. sitive Phase 3 Breast Cancer and Melanoma Results
[ Mon, Dec 08th 2008 ] - Market Wire
Data from Pivotal Study Show Medtronic Deep Brain .. ced Seizure Rate in Patients with Severe Epilepsy
[ Mon, Dec 08th 2008 ] - Market Wire
Orthofix International Reports Previously-Filed False Claims Act Complaint is Unsealed
[ Mon, Dec 08th 2008 ] - Market Wire
ZIOPHARM Presents Positive Darinaparsin Phase II Data at ASH Meeting
[ Mon, Dec 08th 2008 ] - Market Wire
Cypress Bioscience, Inc.: Cypress Bioscience, Inc .. sent at RBC Capital Markets Healthcare Conference
[ Mon, Dec 08th 2008 ] - Market Wire
Premier Cooperative Group in Adult Lymphoma Resea .. ajor Study in Disease s Largest Patient Populati
[ Mon, Dec 08th 2008 ] - Market Wire
Bristol-Myers Squibb and AstraZeneca Announce Exp .. tion to Develop and Commercialize Dapagliflozin i
[ Mon, Dec 08th 2008 ] - Market Wire
Relazione su due presentazioni ASH: Attivit e t .. in pazienti con leucemia linfocitica cronica sin
[ Mon, Dec 08th 2008 ] - Market Wire
Emergent BioSolutions to Webcast Presentation at .. ealthcare Conference on Wednesday, January 14, 20
[ Mon, Dec 08th 2008 ] - Market Wire
Cytori Demonstrates Benefit of Adipose-Derived St .. Cells in Spinal Disc Repair in Preclinical Study
[ Mon, Dec 08th 2008 ] - Market Wire
ImmunoGen, Inc. Announces Genentech s Fifth TAP Technology License
Sun, December 7, 2008
[ Sun, Dec 07th 2008 ] - Market Wire
Crucell N.V.: Crucell Announces Registration of Hepavax-Gene(R) in China
[ Sun, Dec 07th 2008 ] - Market Wire
Exelixis Reports Phase 1 Data for XL019 at ASH Annual Meeting
[ Sun, Dec 07th 2008 ] - Market Wire
ARIAD To Hold Conference Call on Monday Morning, December 8, 2008
[ Sun, Dec 07th 2008 ] - Market Wire
Allos Therapeutics Announces Top Line Results fro .. l of Pralatrexate in Patients with Relapsed or Re
Sat, December 6, 2008
[ Sat, Dec 06th 2008 ] - Market Wire
Seattle Genetics Reports Objective Responses with .. acetuzumab in Phase II Non-Hodgkin Lymphoma Trial
Fri, December 5, 2008
[ Fri, Dec 05th 2008 ] - Market Wire
Health Net and the USO of Metropolitan Washington Team Up for Annual Celebration of Children
[ Fri, Dec 05th 2008 ] - Market Wire
New England Journal of Medicine ver ffentlicht Da .. on Viread bei der Behandlung chronischer Hepatit
[ Fri, Dec 05th 2008 ] - Market Wire
Coventry Health Care Appoints Allen Wise as Executive Chairman
[ Fri, Dec 05th 2008 ] - Market Wire
KV Pharmaceutical Announces Changes in Senior Management
[ Fri, Dec 05th 2008 ] - Market Wire
ONI BioPharma Inc.: ONI BioPharma Announces Proposed Rights Offering to Shareholders
[ Fri, Dec 05th 2008 ] - Market Wire
CytoCore CEO Continues to Purchase Shares of CYOE in the Open Market
[ Fri, Dec 05th 2008 ] - Market Wire
Ore Pharmaceuticals Announces Completion of Multi .. inical Phase 1 Trial; Presents GL1001 Preclinical
[ Fri, Dec 05th 2008 ] - Market Wire
Company Profile for Alphatec Spine
[ Fri, Dec 05th 2008 ] - Market Wire
FDA Advisory Committee to Discuss Genzyme s Synvisc-One PMA on Tuesday
[ Fri, Dec 05th 2008 ] - Market Wire
Candela to Seek Stockholder Approval Prior to Certain Issuances of Preferred Stock
[ Fri, Dec 05th 2008 ] - Market Wire
Cytokinetics, Inc.: Cytokinetics Announces Precli .. a Regarding Ispinesib to Be Presented at the 31st
[ Fri, Dec 05th 2008 ] - Market Wire
St. Jude Medical Announces Neuromodulation Divisi .. rand Identity at 12th Annual North American Neuro
[ Fri, Dec 05th 2008 ] - Market Wire
Resumen: Publicados en el New England Journal of .. an la eficacia de Viread en el tratamiento de la
Thu, December 4, 2008
[ Thu, Dec 04th 2008 ] - Market Wire
PDL BioPharma, Inc.: David Parkinson, M.D. Elected to Facet Biotech's Board of Directors
[ Thu, Dec 04th 2008 ] - Market Wire
AmSurg Corp. to Present at the RBC Capital Markets 2008 Healthcare Conference
[ Thu, Dec 04th 2008 ] - Market Wire
Assisted Living Concepts, Inc.: Assisted Living C .. pts, Inc. to Attend New York Investor Conferences
[ Thu, Dec 04th 2008 ] - Market Wire
SCOR: Moody's upgrades SCOR to 'A2'
[ Thu, Dec 04th 2008 ] - Market Wire
Alnylam Selected as 2009 Technology Pioneer by the World Economic Forum
[ Thu, Dec 04th 2008 ] - Market Wire
Osiris Completes Enrollment in First Worldwide Phase III Stem Cell Trial
[ Thu, Dec 04th 2008 ] - Market Wire
Novelos Therapeutics and Academic Collaborators P .. Posters at 2008 AACR Tumor Immunology Conference
[ Thu, Dec 04th 2008 ] - Market Wire
Tesetaxel, a Leading Oral Taxane in Clinical Deve .. ation as an Orphan Drug for Treatment of Patients
[ Thu, Dec 04th 2008 ] - Market Wire
BioSante Pharmaceuticals Signs Elestrin " Marketing Agreement with Azur Pharma
[ Thu, Dec 04th 2008 ] - Market Wire
Hi-Tech Pharmacal to Release First Quarter Earnings and Hold Conference Call on December 9, 2008
[ Thu, Dec 04th 2008 ] - Market Wire
ImmunoGen, Inc. Announces Webcast of Panel Sessio .. he RBC Capital Markets 2008 Healthcare Conference
[ Thu, Dec 04th 2008 ] - Market Wire
Sirona Announces $50 Million Share Repurchase Authorization
[ Thu, Dec 04th 2008 ] - Market Wire
Centene Corporation Names Aaron W. Brace as President and CEO of South Carolina Subsidiary
Wed, December 3, 2008
[ Wed, Dec 03rd 2008 ] - Market Wire
Alphatec Spine to Present at the RBC Healthcare Conference
[ Wed, Dec 03rd 2008 ] - Market Wire
Zila to Report Fiscal 2009 First Quarter Financia .. s and Host Investor Conference Call on December 8
[ Wed, Dec 03rd 2008 ] - Market Wire
CytoDyn Awarded Global Patents For Modernizing The Treatment of Infectious Diseases
[ Wed, Dec 03rd 2008 ] - Market Wire
PerkinElmer Announces Strategic Acquisition of Arnel Inc.
[ Wed, Dec 03rd 2008 ] - Market Wire
Aspect Medical Systems Repurchases $35 Million of Its 2.5% Convertible Senior Notes Due 2014
[ Wed, Dec 03rd 2008 ] - Market Wire
Health Net Federal Services Is Awarded URAC Healt .. on Management and Case Management Reaccreditation
[ Wed, Dec 03rd 2008 ] - Market Wire
Synta Pharmaceuticals to Participate in the RBC Capital Markets Healthcare Conference
[ Wed, Dec 03rd 2008 ] - Market Wire
Somaxon Pharmaceuticals to Present at the RBC Capital Markets Healthcare Conference
[ Wed, Dec 03rd 2008 ] - Market Wire
Oscient Pharmaceuticals Receives Paragraph IV Certification Notice for ANTARA
[ Wed, Dec 03rd 2008 ] - Market Wire
Protherics PLC: Offer Update
[ Wed, Dec 03rd 2008 ] - Market Wire
Celgene Corporation and Acceleron Pharma to Prese .. nnual Meeting of the American Society of Hematolo
[ Wed, Dec 03rd 2008 ] - Market Wire
Results of Studies of Eslicarbazepine Acetate for .. Be Presented at American Epilepsy Society Annual
[ Wed, Dec 03rd 2008 ] - Market Wire
Zacks Bull and Bear of the Day Highlights: ViroPh .. s, Union Pacific, Methanex and L-3 Communications
Tue, December 2, 2008
[ Tue, Dec 02nd 2008 ] - Market Wire
Dr. Edmund Pezalla Named President of the Pharmacy and Therapeutics Society
[ Tue, Dec 02nd 2008 ] - Market Wire
Adeona Pharmaceuticals, Inc.: Adeona Pharmaceutic .. Research Institute (NNRI) Collaborate to Test Flu
[ Tue, Dec 02nd 2008 ] - Market Wire
Northland Resources Inc.: Northland Resources Inc .. g) Concession Granted for Tapuli Iron Ore Project
[ Tue, Dec 02nd 2008 ] - Market Wire
Theravance, Inc.: GSK and Theravance Announce Pos .. BA, '444 in the Horizon Asthma Development Progra
[ Tue, Dec 02nd 2008 ] - Market Wire
LHC Group Expands Footprint to 16 States with Initial Entry into Oklahoma
[ Tue, Dec 02nd 2008 ] - Market Wire
Metabolic Research, Inc. Expands Broadcast Programs
[ Tue, Dec 02nd 2008 ] - Market Wire
Targeted Genetics: Targeted Genetics Realigns Pro .. Priorities and Implements Cost Reduction Measures
[ Tue, Dec 02nd 2008 ] - Market Wire
Protalix BioTherapeutics Announces Completion of .. votal Phase III Clinical Trial of Gaucher Disease
[ Tue, Dec 02nd 2008 ] - Market Wire
Oculus Innovative Sciences Announces Agreement wi .. Development of Microcyn Technology Use in Taiwa
[ Tue, Dec 02nd 2008 ] - Market Wire
BIOLASE Technology, Inc.: BIOLASE Cuts Quarterly Fixed Costs by $2 Million or 20 Percent
[ Tue, Dec 02nd 2008 ] - Market Wire
VIVUS to Present at J.P. Morgan 2008 SMid Cap Conference
[ Tue, Dec 02nd 2008 ] - Market Wire
Applied Biosystems " Part of Life Technologies .. spond to Melamine Contamination in Dairy Products
[ Tue, Dec 02nd 2008 ] - Market Wire
Titan Pharmaceuticals Announces Reduction in Force
Mon, December 1, 2008
[ Mon, Dec 01st 2008 ] - Market Wire
Chembio Diagnostics, Inc.: Chembio Donates HIV Te .. to Support World AIDS Day 2008 Testing Initiative
[ Mon, Dec 01st 2008 ] - Market Wire
Healthline Networks, Inc.: Healthline Networks Se .. h and Advertising Partner for Optumhealth's New C
[ Mon, Dec 01st 2008 ] - Market Wire
DIANOR RESOURCES INC.: Dianor Resources Signs Def .. ition of Surface Rights to Leadbetter Extension P
[ Mon, Dec 01st 2008 ] - Market Wire
FONAR Corporation: FONAR Granted Continued Listing by NASDAQ Panel
[ Mon, Dec 01st 2008 ] - Market Wire
OptumHealth Launches Consumer-Focused Health Info .. pon Its Expertise in Serving 60 Million Americans
[ Mon, Dec 01st 2008 ] - Market Wire
DexComTM Receives CE Mark Approval for the SEVEN Continuous Glucose Monitoring System
[ Mon, Dec 01st 2008 ] - Market Wire
Del Medical Systems Group Launches TITAN Family of Digital Radiographic Systems
[ Mon, Dec 01st 2008 ] - Market Wire
OR-Live, Inc.: REMINDER: MAKOplasty(R) Robotic Ar .. tial Knee Resurfacing -- A New Level of Precision
[ Mon, Dec 01st 2008 ] - Market Wire
Imaging3, Inc.: Imaging3 CEO Opens RSNA 2008 Conf .. ages and Interview With Leading Trade Publication
[ Mon, Dec 01st 2008 ] - Market Wire
SonoSite Announces the New S-GYN "
[ Mon, Dec 01st 2008 ] - Market Wire
Acorda Therapeutics Elects John P. Kelley to Board of Directors
[ Mon, Dec 01st 2008 ] - Market Wire
Spectrum Pharmaceuticals to Host Conference Call .. ling ZEVALIN Joint Venture and Near-Term Strategy
[ Mon, Dec 01st 2008 ] - Market Wire
Pluristem Retains KKS as Its CRO for Upcoming Limb Ischemia Clinical Trial
Sun, November 30, 2008
[ Sun, Nov 30th 2008 ] - Market Wire
Regulus Therapeutics, Alnylam Pharmaceuticals, an .. Ever In Vivo Efficacy Data for a microRNA Therap
Fri, November 28, 2008
[ Fri, Nov 28th 2008 ] - Market Wire
SCOR: SCOR establishes reinsurance subsidiary in Moscow
[ Fri, Nov 28th 2008 ] - Market Wire
Schaeffer's Early Edge: eBay, Eli Lilly, and Yahoo!
[ Fri, Nov 28th 2008 ] - Market Wire
MoneyTV; Mutual Merchant Services, Inc.; Imaging3 .. ca, Inc.; OriginOil, Inc.: MoneyTV, Week of 11/28
Thu, November 27, 2008
[ Thu, Nov 27th 2008 ] - Market Wire
Geron Issues Statement Regarding European Patent Office Decision in WARF Patent Appeal
[ Thu, Nov 27th 2008 ] - Market Wire
FORTIS: Herman Verwilst to Step Down From Fortis Board of Directors
[ Thu, Nov 27th 2008 ] - Market Wire
SORIN GROUP FIRMA ACCORDO DI ACQUISIZIONE DEL BUS .. ELIEVO ENDOSCOPICO DI VASI SANGUIGNI DA DATASCOPE
Wed, November 26, 2008
[ Wed, Nov 26th 2008 ] - Market Wire
Mentor to Present at the Piper Jaffray 20th Annual Health Care Conference
[ Wed, Nov 26th 2008 ] - Market Wire
Osiris Therapeutics to Present at 20th Annual Piper Jaffray Health Care Conference
[ Wed, Nov 26th 2008 ] - Market Wire
Oculus Innovative Sciences Receives NASDAQ Notification
[ Wed, Nov 26th 2008 ] - Market Wire
Alliance Imaging to Present at the Piper Jaffray Health Care Conference
[ Wed, Nov 26th 2008 ] - Market Wire
Alnylam to Webcast Presentation at the 20th Annual Piper Jaffray Health Care Conference
[ Wed, Nov 26th 2008 ] - Market Wire
Micrus Endovascular to Present at Piper Jaffray 20th Annual Unplugged Health Care Conference
[ Wed, Nov 26th 2008 ] - Market Wire
MedaSorb Technologies Corporation: MedaSorb Techn .. Jones M.D., Elected President of the Renal Physi
[ Wed, Nov 26th 2008 ] - Market Wire
Psychiatric Solutions to Present at the JPMorgan SMid Cap Conference
[ Wed, Nov 26th 2008 ] - Market Wire
Somatic Systems, Inc.: Somatic Systems, Inc. National Television Show Airings Begin
[ Wed, Nov 26th 2008 ] - Market Wire
Mannatech Congratulates Team Mannatech " Athletes on Recent Accomplishments
[ Wed, Nov 26th 2008 ] - Market Wire
Wyeth and Progenics Announce Positive Outcome of .. cutaneous RELISTOR for Opioid-Induced Constipatio
[ Wed, Nov 26th 2008 ] - Market Wire
Tarceva (erlotinib) Endorsed by the U.K. s Nati .. nd Clinical Excellence for Use in Patients with A
Tue, November 25, 2008
[ Tue, Nov 25th 2008 ] - Market Wire
KCI s LifeCell Granted CE Mark for its Strattice Reconstructive Tissue Matrix
[ Tue, Nov 25th 2008 ] - Market Wire
Webcast Alert: Interview with Jay Higham, CEO, IntegraMed America
[ Tue, Nov 25th 2008 ] - Market Wire
Dynavax Announces Listing Transfer to The Nasdaq Capital Market from The Nasdaq Global Market
[ Tue, Nov 25th 2008 ] - Market Wire
Proxy Organizer Responds to Most Recent Improper Actions by Artes Medical
[ Tue, Nov 25th 2008 ] - Market Wire
Health Net Names Chief Medical Officer
[ Tue, Nov 25th 2008 ] - Market Wire
Abraxis BioScience Announces Agreement to Re-Acqu .. ABRAXANE; Company Highlights Plans to Initiate Ni
[ Tue, Nov 25th 2008 ] - Market Wire
Protalix BioTherapeutics to Present at the Piper Jaffray 20th Annual Health Care Conference
[ Tue, Nov 25th 2008 ] - Market Wire
Optimer Pharmaceuticals to Present at the 20th Annual Piper Jaffray Health Care Conference
[ Tue, Nov 25th 2008 ] - Market Wire
Enrollment in Provectus Phase 2 Melanoma Clinical Trial Reaches Halfway Point
[ Tue, Nov 25th 2008 ] - Market Wire
Inspire Announces Webcast of Presentation at Piper Jaffray Conference
[ Tue, Nov 25th 2008 ] - Market Wire
Cytori Strengthens European Union Sales, Training and Service Operations
[ Tue, Nov 25th 2008 ] - Market Wire
Acorda Therapeutics to Present at the Piper Jaffray 20th Annual Healthcare Conference
Mon, November 24, 2008
[ Mon, Nov 24th 2008 ] - Market Wire
Crucell N.V.: DSM Biologics and Crucell Announce .. PER.C6(R) Licensing Agreement with Gedeon Richter
[ Mon, Nov 24th 2008 ] - Alexa Nuessle
TEEN SUICIDES THIRD LEADING CAUSE OF DEATH Teen Suicide is a Preventable Public Health Problem
[ Mon, Nov 24th 2008 ] - Market Wire
New Noninvasive Prenatal Diagnostic Technology Al .. Diseases Such as Cystic Fibrosis Caused by Single
[ Mon, Nov 24th 2008 ] - Market Wire
DexCom to Present at the Piper Jaffray 20th Annual Health Care Conference
[ Mon, Nov 24th 2008 ] - Market Wire
Roderick de Greef Named Chairman of Cambridge Heart Board of Directors
[ Mon, Nov 24th 2008 ] - Market Wire
U.S. FDA Grants Pralatrexate Orphan Drug Designat .. nt of Patients with Diffuse Large B-Cell Lymphoma
[ Mon, Nov 24th 2008 ] - Market Wire
Alkermes Corporate Presentation to be Webcast at the NASDAQ Investor Program
[ Mon, Nov 24th 2008 ] - Market Wire
TomoTherapy Names Rafael Vaello Vice President of Global Sales
[ Mon, Nov 24th 2008 ] - Market Wire
Celsion Announces the Appointment of Sean Moran as Chief Financial Officer
[ Mon, Nov 24th 2008 ] - Market Wire
Genzyme Seeks U.S. Approval for Clolar to Treat Adult AML
[ Mon, Nov 24th 2008 ] - Market Wire
OSI Pharmaceuticals to Webcast its R&D Analyst Day on Thursday,December 4th
[ Mon, Nov 24th 2008 ] - Market Wire
Medtronic Names Francine Kaufman, M.D. to Key Executive Role in Diabetes Business
[ Mon, Nov 24th 2008 ] - Market Wire
LifePoint Hospitals Names Michael S. Coggin Chief Accounting Officer
Thu, November 20, 2008
[ Thu, Nov 20th 2008 ] - Market Wire
HealthSpring, Inc. Announces Retirement of Chief Financial Officer, Kevin M. McNamara
[ Thu, Nov 20th 2008 ] - Market Wire
Solvay Pharmaceuticals, Inc. Announces Exclusive .. ent with Depomed, Inc. for Gabapentin GR® for th
[ Thu, Nov 20th 2008 ] - Market Wire
Magellan Health Services to Release 2009 Financial Guidance on December 17, 2008
[ Thu, Nov 20th 2008 ] - Market Wire
Endologix Announces Favorable Powerlink XL Clinical Trial Results
[ Thu, Nov 20th 2008 ] - Market Wire
Chembio Diagnostics, Inc.: Chembio Ships First DPP(R) Tests
[ Thu, Nov 20th 2008 ] - Market Wire
Trinity Biotech: Trinity Biotech Announces Appoin .. ent of Clint Severson as a Non-Executive Director
[ Thu, Nov 20th 2008 ] - Market Wire
Oscient Pharmaceuticals Announces Determination o .. the Consideration Issuable in its Exchange Offer
[ Thu, Nov 20th 2008 ] - Market Wire
OR-Live, Inc.: REMINDER: Prostate Cancer Treatmen .. Using Minimally Invasive Cutting Edge Technology
[ Thu, Nov 20th 2008 ] - Market Wire
Cougar Biotechnology Announces Initiation of Phas .. erone Acetate) in Advanced Breast Cancer Patients
[ Thu, Nov 20th 2008 ] - Market Wire
Synta Pharmaceuticals Announces First Patient Tre .. /2Clinical Trial of Elesclomol in Prostate Cancer
[ Thu, Nov 20th 2008 ] - Market Wire
Alnylam Presents Pre-clinical Data from TTR Amyloidosis DevelopmentProgram
[ Thu, Nov 20th 2008 ] - Market Wire
Akorn Enters into a Five Year Contract Manufacturing Agreement toSupply an Ophthalmic Product
Wed, November 19, 2008
[ Wed, Nov 19th 2008 ] - Market Wire
BioTime CEO Dr. Michael West Announces the Launch .. the State of the Stem Cell Industry under the Ob
[ Wed, Nov 19th 2008 ] - Market Wire
Imaging3, Inc.: Imaging3 to Debut 3D Real-Time Im .. and Perspective Interface at the RSNA Trade Show
[ Wed, Nov 19th 2008 ] - Market Wire
Symbollon Pharmaceuticals, Inc.: Symbollon Initiates Sales of IoGen Through Web Site BuyIoGen.com
[ Wed, Nov 19th 2008 ] - Market Wire
El armazón de colágeno de ReGen Biologics r .. recomendacionespositivas del panel ortopédico
[ Wed, Nov 19th 2008 ] - Market Wire
Bond Laboratories Inc. Reports Third Quarter 2008 Results
[ Wed, Nov 19th 2008 ] - Market Wire
Cutera to Present at the Piper Jaffray 20th Annual Health CareConference
[ Wed, Nov 19th 2008 ] - Market Wire
Syneron Medical Ltd.: Syneron Medical Announces the Establishment of Syneron China
[ Wed, Nov 19th 2008 ] - Market Wire
Sanguine Corporation: Sanguine Corporation Announ .. tent to Acquire an MRI Imaging Technology Company
[ Wed, Nov 19th 2008 ] - Market Wire
Inhibiton Therapeutics Announces the Addition of Aaron A. Grunfeld toIts Board of Directors
[ Wed, Nov 19th 2008 ] - Market Wire
Seven Investigator-Initiated Clinical Studies Announced
[ Wed, Nov 19th 2008 ] - Market Wire
Randomized Phase 2 Study of IMC-A12 for HER2-Expr .. dvancedBreast Cancer Commences Patient Enrollment
[ Wed, Nov 19th 2008 ] - Market Wire
GenVec Announces Interim Survival Data in Pivotal .. TNFerade"¢in Locally Advanced Pancreatic Cancer
Tue, November 18, 2008
[ Tue, Nov 18th 2008 ] - Market Wire
ReGen Biologics Collagen Scaffold Receives Positive Orthopaedic PanelRecommendations
[ Tue, Nov 18th 2008 ] - Market Wire
Sirona Dental Systems, Inc. Fiscal 2008 Fourth Qu .. l YearEarnings Release Scheduled for December 4th
[ Tue, Nov 18th 2008 ] - Market Wire
Lime Energy Co. Reports Capital Raise and Debt Reduction
[ Tue, Nov 18th 2008 ] - Market Wire
LifeVantage Corporation Announces 1Q FY 2009 Financial and OperatingResults
[ Tue, Nov 18th 2008 ] - Market Wire
FORTIS: Fortis holding statement on Belgian court ruling
[ Tue, Nov 18th 2008 ] - Market Wire
BioSpheres UFE Awareness Campaign Continues with NBC-TV Today ShowAppearance by Beverly Johnson
[ Tue, Nov 18th 2008 ] - Market Wire
FDA Extends METOZOLV"¢ ODT Review Date
[ Tue, Nov 18th 2008 ] - Market Wire
Salix Announces Issuance of U.S. Patent for Rifaximin
[ Tue, Nov 18th 2008 ] - Market Wire
Immunosyn Corporation Files 10-Q
[ Tue, Nov 18th 2008 ] - Market Wire
Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. e Piper Jaffray 20th Annual Healthcare Conference
[ Tue, Nov 18th 2008 ] - Market Wire
StemCells, Inc. Closes $20 Million Equity Financing
[ Tue, Nov 18th 2008 ] - Market Wire
Metcare of Florida Scores High Marks in DSS Research Survey on PatientSatisfaction
Mon, November 17, 2008
[ Mon, Nov 17th 2008 ] - Market Wire
Resumen: Gilead Sciences anuncia notificación de presentación ANDA para Truvada
[ Mon, Nov 17th 2008 ] - Market Wire
Webcast Alert: Lpath Third Quarter Business Review Teleconference
[ Mon, Nov 17th 2008 ] - Market Wire
Vicor Technologies, Inc.: Vicor Technologies Issu .. scusses Milestones, Progress Towards Commercializ
[ Mon, Nov 17th 2008 ] - Market Wire
Somatic Systems, Inc.: Somatic Systems, Inc. Comp .. t Round of Financials for Audits for OTCBB Uplist
[ Mon, Nov 17th 2008 ] - Market Wire
Altus Pharmaceuticals Reaffirms Plan to Submit New Drug Applicationfor Trizytek Approval
[ Mon, Nov 17th 2008 ] - Market Wire
OraSure Technologies to Participate at the Lazard Capital Markets5th Annual Healthcare Conference
[ Mon, Nov 17th 2008 ] - Market Wire
Targeted Genetics: Targeted Genetics' Board of Di .. G. Susan Robinson, President and CEO, as Director
[ Mon, Nov 17th 2008 ] - Market Wire
Juanell Hefner Named President of MHN
[ Mon, Nov 17th 2008 ] - Market Wire
Patients Experienced Nearly a 70% Reduction in Pa .. When Using MPMMedical's Regenecare Wound Care Gel
[ Mon, Nov 17th 2008 ] - Market Wire
St. Jude Medical Announces Japanese Approval and Launch of VictoryFamily of Pacemakers
[ Mon, Nov 17th 2008 ] - Market Wire
ZYTO Corp Announces Profitable Q3 08
[ Mon, Nov 17th 2008 ] - Market Wire
SciClone Pharmaceuticals, Inc.: SciClone Reaches .. Protocol Assessment for Phase 3 Thymalfasin Tria

Biovail Announces Filing of ANDA for Quetiapine XR Tablets


//health-fitness.news-articles.net/content/2008/ .. es-filing-of-anda-for-quetiapine-xr-tablets.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


TORONTO--([ BUSINESS WIRE ])--Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that the United States Food and Drug Administration (FDA) has accepted the Company's abbreviated new drug application (ANDA) for a generic formulation of 200mg, 300mg and 400mg strengths of quetiapine fumarate extended-release tablets (sold under the brand name Seroquel XR by AstraZeneca Pharmaceuticals LP). This represents Biovail's third successful ANDA filing in 2008.

Seroquel XR is an atypical antipsychotic agent indicated for the treatment of schizophrenia and bipolar disorder. The product is available in 150mg, 200mg, 300mg and 400mg strengths. According to IMS Health, Seroquel XR generated U.S. revenues of approximately $166 million in the twelve-month period ended September 30, 2008.

About Biovail Corporation

Biovail Corporation is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products. The Company is focused on the development and commercialization of medicines that address unmet medical needs in niche specialty central nervous system (CNS) markets. For more information about Biovail, visit the Company's Web site at [ www.biovail.com ].

For further information, please contact Nelson F. Isabel at 905-286-3000 or send inquiries to [ ir@biovail.com ].


Publication Contributing Sources